yttrium has been researched along with Bladder Cancer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SK; Flaig, TW; Mao, C; Park, W; Su, LJ; Wolenski, CD | 1 |
| Castelli, E; Collura, D; Coverlizza, S; D'Urso, L; Demarchi, A; Giacobbe, A; Muto, G; Muto, GL | 1 |
| WALKER, LA | 1 |
| EINHORN, J; LARSSON, LG; RAGNHULT, I | 1 |
| Dimopoulos, K; Karagiannis, A; Karayannis, D; Sakkas, G | 1 |
| Fajardo, LF; Kabalin, JN; Mancianti, ML; Terris, MK | 1 |
| Algaba, F; Laguna, P; Salvador, J; Vicente, J | 1 |
1 review(s) available for yttrium and Bladder Cancer
| Article | Year |
|---|---|
RADIOACTIVE YTTRIUM 90: A REVIEW OF ITS PROPERTIES, BIOLOGICAL BEHAVIOR, AND CLINICAL USES.
Topics: Chelating Agents; Kidney Function Tests; Liver Function Tests; Neoplasms; Peritoneal Neoplasms; Radioactivity; Urinary Bladder Neoplasms; Yttrium; Yttrium Isotopes | 1964 |
2 trial(s) available for yttrium and Bladder Cancer
| Article | Year |
|---|---|
Laser treatment in urology: our experience with neodymium:YAG and carbon dioxide lasers.
Topics: Adult; Aged; Carcinoma, Transitional Cell; Condylomata Acuminata; Female; Female Urogenital Diseases; Humans; Kidney Neoplasms; Laser Coagulation; Male; Male Urogenital Diseases; Middle Aged; Neodymium; Neoplasm Recurrence, Local; Urinary Bladder Neoplasms; Yttrium | 1995 |
Histological evaluation of superficial bladder tumors treated by Nd-YAG laser and transurethral resection.
Topics: Aluminum; Carcinoma in Situ; Cystectomy; Follow-Up Studies; Humans; Light Coagulation; Minerals; Neodymium; Neoplasm Recurrence, Local; Neoplasm Staging; Time Factors; Urinary Bladder; Urinary Bladder Neoplasms; Yttrium | 1991 |
4 other study(ies) available for yttrium and Bladder Cancer
| Article | Year |
|---|---|
Multifunctional nanoclusters of NaYF
Topics: Antibodies; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; ErbB Receptors; Erbium; Fluorides; Gold; Humans; Lasers; Luminescent Measurements; Microscopy, Fluorescence; Nanoparticles; Nanotubes; Urinary Bladder Neoplasms; Ytterbium; Yttrium | 2019 |
Thulium:yttrium-aluminum-garnet laser for en bloc resection of bladder cancer: clinical and histopathologic advantages.
Topics: Adult; Aged; Aged, 80 and over; Aluminum; Cystectomy; Disease Progression; Endoscopy; Female; Follow-Up Studies; Humans; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Prospective Studies; Recurrence; Thulium; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Yttrium | 2014 |
Radioactive yttrium (Y90) as a possible adjunct in the treatment of papillomatosis of the urinary bladder.
Topics: Humans; Papilloma; Radioactivity; Urinary Bladder Neoplasms; Yttrium; Yttrium Radioisotopes | 1955 |
Dosimetry studies utilizing the urolase right-angle firing neodymium:YAG laser fiber in the human prostate.
Topics: Adult; Aged; Aluminum Silicates; Carcinoma, Transitional Cell; Cystectomy; Energy Transfer; Epithelium; Equipment Design; Fiber Optic Technology; Fibrosis; Follow-Up Studies; Hot Temperature; Humans; Laser Coagulation; Male; Metaplasia; Middle Aged; Neodymium; Prostate; Prostatectomy; Prostatic Neoplasms; Time Factors; Urethra; Urinary Bladder Neoplasms; Yttrium | 1996 |